ArticleNPJ precision oncology2024

Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy.

Ze Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.